Ubs Group Ag Profound Medical Corp. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Profound Medical Corp. stock. As of the latest transaction made, Ubs Group Ag holds 3,755 shares of PROF stock, worth $22,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,755

Previous 776 383.89%

Holding current value

$22,041

Previous $4,000 450.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.04 - $6.86 $12,035 - $20,435	2,979 Added 383.89%	3,755 $22,000
Q1 2025 May 13, 2025	BUY	$5.81 - $7.9 $4,508 - $6,130	776 New	776 $4,000
Q2 2024 Aug 13, 2024	BUY	$7.25 - $9.07 $12,441 - $15,564	1,716 Added 266.05%	2,361 $19,000
Q1 2024 May 13, 2024	BUY	$7.3 - $9.46 $4,708 - $6,101	645 New	645 $5,000
Q4 2022 Feb 08, 2023	SELL	$3.18 - $10.91 $12,332 - $42,308	-3,878 Reduced 65.24%	2,066 $22,000
Q3 2022 Nov 10, 2022	BUY	$3.99 - $9.3 $22,898 - $53,372	5,739 Added 2799.51%	5,944 $24,000
Q2 2022 Aug 10, 2022	BUY	$6.34 - $9.53 $1,299 - $1,953	205 New	205 $1,000
Q1 2022 May 16, 2022	SELL	$8.16 - $11.33 $11,652 - $16,179	-1,428 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $14,822 - $21,705	1,428 New	1,428 $16,000
Q2 2021 Aug 13, 2021	SELL	$16.0 - $20.59 $4,800 - $6,177	-300 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$19.16 - $28.09 $38,320 - $56,180	-2,000 Reduced 86.96%	300 $6,000
Q4 2020 Feb 11, 2021	SELL	$16.4 - $22.9 $8,068 - $11,266	-492 Reduced 17.62%	2,300 $47,000
Q3 2020 Nov 12, 2020	BUY	$14.05 - $18.13 $4,524 - $5,837	322 Added 13.04%	2,792 $49,000
Q2 2020 Jul 31, 2020	SELL	$9.41 - $16.94 $10,115 - $18,210	-1,075 Reduced 30.32%	2,470 $42,000
Q1 2020 May 01, 2020	BUY	$6.88 - $19.7 $19,573 - $56,046	2,845 Added 406.43%	3,545 $34,000
Q4 2019 Feb 14, 2020	BUY	$6.4 - $11.95 $4,480 - $8,365	700 New	700 $8,000

Others Institutions Holding PROF

# of Institutions

Shares Held

12.6M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $122M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account